Clinical Trial Update: Finerenone for Patients With Primary Aldosteronism (FAIRY) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating finerenone for primary aldosteronism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Qifu Li | Conditions: Primary Aldosteronism | Phase 4 | Status: RECRUITING